John Markels Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

John Markels is of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 71,384 shares of SGMO, which is worth approximately $32,122. The most recent transaction as insider was on Jun 04, 2024, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.4K
53.9% 3M change
53.9% 12M change
Total Value Held $32,122

John Markels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 25.94%
71,384 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
13,900 Added 23.06%
46,384 Common Stock
Jun 03 2022
BUY
Open market or private purchase
$25,033 $3.69 p/Share
6,784 Added 17.28%
32,484 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 32.72%
25,700 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
8,200 Added 38.32%
13,200 Common Stock

Also insider at

ARCT
Arcturus Therapeutics Holdings Inc. Healthcare
Director
JM

John Markels

Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO